Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)-Reference-Cited by-同舟云学术

Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)

Published:2015-09-03 Issue:S3 Volume:22 Page:1067-1074
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Oki Eiji, ,Emi Yasunori,Miyamoto Yuji,Kabashima Akira,Higashi Hidefumi,Ogata Yutaka,Ikebe Masahiko,Saeki Hiroshi,Tokunaga Shoji,Shirabe Ken,Beppu Toru,Uchida Shinji,Takatsuki Mitsuhisa,Sakoda Masahiko,Eguchi Susumu,Akagi Yoshito,Kakeji Yoshihiro,Baba Hideo,Natsugoe Shoji,Maehara Yoshihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-015-4771-1.pdf

Reference30 articles.

1. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.

2. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989;210:127–38.

3. Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol. 2013;31:1931–8.

4. Foster JH. Treatment of metastatic disease of the liver: a skeptic’s view. Semin Liver Dis. 1984;4:170–9.

5. Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:1065–75.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence‐risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases;Journal of Surgical Oncology;2024-01-18

2. Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer;Journal of the Anus, Rectum and Colon;2022-01-28

3. Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer;J ANUS RECTUM COLON;2022

4. Proposal of a novel H category‐based classification of colorectal liver metastases based on a Japanese nationwide survey;Journal of Hepato-Biliary-Pancreatic Sciences;2021-03-16

5. Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials;International Journal of Clinical Oncology;2019-07-22